scPharmaceuticals to Present at the 42nd Annual Cowen Healthcare Conference

Rhea-AI Summary

BURLINGTON, Mass., Feb. 16, 2022 – scPharmaceuticals (Nasdaq: SCPH) announced that John Tucker, CEO, will present at the 42nd Annual Cowen Healthcare Conference on March 8 at 1:30 PM EST. The company focuses on optimizing therapies and reducing healthcare costs through innovative products, particularly in outpatient care for heart failure and infectious diseases. A live webcast of the presentation will be available on the company's website. For more information about scPharmaceuticals, visit www.scpharmaceuticals.com.

BURLINGTON, Mass., Feb. 16, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the 42^nd Annual Cowen Healthcare Conference on Tuesday, March 8 at 1:30pm EST.

A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com 

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com 

FAQ

When is scPharmaceuticals scheduled to present at the Cowen Healthcare Conference?

scPharmaceuticals is scheduled to present on March 8, 2022, at 1:30 PM EST.

What is the focus of scPharmaceuticals' products?

scPharmaceuticals focuses on developing products that optimize therapies, improve patient care, and reduce healthcare costs.

Where can I watch the scPharmaceuticals conference presentation?

The presentation can be accessed via a live webcast on scPharmaceuticals' website under 'News & Events' in the Investor Relations section.

What conditions do scPharmaceuticals' lead programs target?

The lead programs of scPharmaceuticals focus on heart failure and infectious disease, specifically subcutaneous self-administration of IV-strength treatments.

What is the stock symbol for scPharmaceuticals?

The stock symbol for scPharmaceuticals is SCPH.